Total financing of €7.5M comprises approximately €5M in venture/equity from existing business angels, current investor with IBG funds and GETEC Family Office, plus a €2.5M grant from the European Commission (EIC Accelerator). Round referred to as Series A1.
About RAYDIAX
MedTech startup developing a therapy-assistance computed tomography system called TACT, specifically designed for minimally invasive cancer interventions in the operating room.
Magdeburg, Germany
Read Company Profile
Source: https://techfundingnews.com/e7-5m-for-raydiax-to-trial-therapy-ct-scanner-in-oncology-workflows/
Frequently Asked Questions
What type of funding round did RAYDIAX raise?
RAYDIAX raised a series-a round.
How much did RAYDIAX raise in its series-a?
RAYDIAX raised $7,500,000 EUR in its series-a.
When did RAYDIAX raise its series-a?
RAYDIAX raised its series-a on 2026-03-03.
Who invested in RAYDIAX's series-a?
The investors in RAYDIAX's series-a are: Existing business angels, IBG funds (current investor), GETEC Family Office (Dr. Karl Gerhold), bmp Ventures.
What type of investment was RAYDIAX's series-a?
RAYDIAX's series-a was a equity investment.
How will RAYDIAX use the funds from its series-a?
RAYDIAX plans to use the funds for: Conduct first-in-human clinical studies to generate early clinical evidence, Advance system to series maturity to meet reliability, performance and regulatory expectations, Build out sales, production and quality structures for commercial installations.